Changeflow GovPing Healthcare Pharmacy Surveillance and Intervention System f...
Routine Notice Added Final

Pharmacy Surveillance and Intervention System for Monitoring, Detecting and Preventing Narcotic Abuse

Favicon for changeflow.com USPTO Patent Grants - Health Informatics (G16H)
Published
Detected
Email

Summary

USPTO granted patent US12603166B2 to OneSource Solutions International, Inc. The patent covers an AI-powered pharmacy surveillance system that integrates real-time prescription records, refill timelines, prescriber data, and patient histories to detect prescription abuse, dosage escalation, and refill velocity anomalies. The system routes structured alerts to pharmacists and regulatory personnel through a secure, role-authenticated interface, with transactions captured by a Medical Data Governance layer using cryptographic sealing and blockchain-based immutable ledger storage.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

USPTO granted patent US12603166B2 to OneSource Solutions International, Inc., covering a pharmacy-level surveillance system using artificial intelligence to monitor prescription behaviors and detect narcotic abuse. The system integrates real-time prescription records, refill timelines, prescriber data, patient histories, and PDMP registries with configurable heuristics and machine-learned models. When anomalies are identified, structured alerts route to pharmacists, prescribers, or regulatory personnel through a secure communication interface, with all transactions captured by a Medical Data Governance layer using cryptographic sealing and blockchain-based immutable ledger storage.

Pharmaceutical companies and healthcare providers implementing prescription monitoring systems should note this patent covers AI-driven detection of overlapping providers, dosage escalation, refill velocity, and prescriber clustering. The system includes a feedback-driven adaptive architecture enabling automatic updates based on real-time outcomes and public health signals. Organizations developing similar prescription abuse detection tools should evaluate freedom-to-operate considerations relative to this intellectual property.

Archived snapshot

Apr 19, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Pharmacy surveillance and intervention system for monitoring, detecting and preventing narcotic abuse

Grant US12603166B2 Kind: B2 Apr 14, 2026

Assignee

OneSource Solutions International, Inc.

Inventors

Harold Arkoff, Vedran Jukic

Abstract

A system and method for pharmacy-level surveillance of all prescription behaviors using one or more artificial intelligence (AI) agents integrated with real-time prescription records, refill timelines, prescriber data, patient histories, PDMP registries, and epidemiological signals. The system evaluates these inputs with configurable heuristics and machine-learned models to detect prescription abuse, public health risks, and equity or bias trends, including overlapping providers, dosage escalation, refill velocity, and prescriber clustering. When an anomaly is identified, a structured alert is routed to pharmacists, prescribers, or regulatory personnel through a secure, role-authenticated communication interface. Each system transaction and user outcome is captured by a Medical Data Governance (MDG) layer, providing cryptographic sealing, timestamping, and immutable ledger storage. In some embodiments, the audit log uses a blockchain-based distributed ledger. The system's feedback-driven, adaptive architecture enables analytic and policy modules to update automatically based on real-time outcomes, public health signals, and usage trends.

CPC Classifications

G16H 20/10 G16H 40/20 G16H 10/60

Filing Date

2025-07-16

Application No.

19271473

Claims

20

View original document →

Get daily alerts for USPTO Patent Grants - Health Informatics (G16H)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 14th, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12603166B2

Who this affects

Applies to
Pharmaceutical companies Healthcare providers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent grant Prescription monitoring AI system deployment
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Artificial Intelligence Data Privacy

Get alerts for this source

We'll email you when USPTO Patent Grants - Health Informatics (G16H) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!